跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,101 条关于
“AAV9-GM2”
全部
2,101
临床试验
1,087
药物
765
机构
7
资讯
242
上个月
Andelyn Biosciences Partners with Queen's University to Manufacture AAV9-GM2 Gene Therapy for GM2 Gangliosidoses
去年
MEDIPAL Holdings and JCR Pharmaceuticals Partner on Novel GM2 Gangliosidosis Therapy JR-479
3个月前
Azafaros Publishes Phase 2 RAINBOW Study Data for Nizubaglustat in GM2 Gangliosidosis and Niemann-Pick Type C Disease
去年
UMass Chan Gene Therapy Shows Biochemical Correction in GM2 Gangliosidosis Phase I/II Trial
去年
Azafaros' Nizubaglustat Gains Orphan Drug Designations, Phase 3 Trials to Start in 2025
7个月前
Azafaros to Present Phase 3 Nizubaglustat Data for Rare Lysosomal Storage Disorders at WORLDSymposium 2026
去年
Azafaros to Present at J.P. Morgan's 43rd Annual Healthcare Conference
上个月
Genezen and Raiden Science Foundation Partner to Advance First AAV9 Gene Replacement Therapy for UBA5 Disorder Toward Clinical Trial
去年
Azafaros Secures €130M Funding to Advance Nizubaglustat into Phase III for Rare Lysosomal Storage Disorders
去年
Azafaros Secures €132M Series B Financing to Advance Rare Lysosomal Storage Disorder Treatments
第 1 页,共 25 页
上一页
下一页